The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

Applications for ALBUS 2024 will be accepted between 01/11/2023 and 30/04/2024.

Please click here to apply.

To see the 2023 ALBUS Award winners please click here.


Supporting Investigational Research

A panel of international prestige jury members

Previous edition awardees